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Abstract
This work aimed tomeasure the in vivo quantification errors obtained when ray-based iterative reconstruction is used in micro–single-
photon emission computed tomography (SPECT). This was investigated with an extensive phantom-based evaluation and two typical
in vivo studies using 99mTc and 111In, measured on a commercially available cadmium zinc telluride (CZT)-based small-animal scanner.
Iterative reconstruction was implemented on the GPU using ray tracing, including (1) scatter correction, (2) computed tomography–
based attenuation correction, (3) resolution recovery, and (4) edge-preserving smoothing. It was validated using a National Electrical
Manufacturers Association (NEMA) phantom. The in vivo quantification error was determined for two radiotracers: [99mTc]DMSA in
naive mice (n 5 10 kidneys) and [111In]octreotide in mice (n 5 6) inoculated with a xenograft neuroendocrine tumor (NCI-H727). The
measured energy resolution is 5.3% for 140.51 keV (99mTc), 4.8% for 171.30 keV, and 3.3% for 245.39 keV (111In). For 99mTc, an
uncorrected quantification error of 286 3% is reduced to 8 6 3%. For 111In, the error reduces from 266 14% to 6 6 22%. The in vivo error
obtainedwith 99mTc-dimercaptosuccinic acid ([99mTc]DMSA) is reduced from 16.26 2.8% to20.36 2.1% and from 16.76 10.1% to 2.26
10.6% with [111In]octreotide. Absolute quantitative in vivo SPECT is possible without explicit system matrix measurements. An
absolute in vivo quantification error smaller than 5% was achieved and exemplified for both [99mTc]DMSA and [111In]octreotide.
A BSOLUTE QUANTIFICATION is very important inin vivo preclinical single-photon emission computed
tomography (SPECT) because it enables the estimation of
radioligand-specific binding kinetics, receptor density, and
other relevant biologic parameters.1 This can lead to faster
drug development,2 improved organ dose estimation
accuracy,3 improved follow-up, and reduced variability
in experimental design in microSPECT studies as the
animals can serve as their own control4 in a longitudinal
setting.
However, several issues can lead to inaccurate quanti-
fication. These errors, attributed to attenuation, scattering,
partial volume effect (PVE), and system imperfections,5
can be compensated for within an iterative reconstruction
framework.6 One approach is to measure the system
response on a grid of discrete locations in the field of view
(FOV).7 These measurements combine geometric response
with more complex effects, such as detector variability and
collimator imperfections. Although easy to measure in
completely stationary systems, this is more difficult in
rotating systems due to imperfect mechanical motion.8 A
different approach is to directly incorporate the physical
processes leading to these effects (eg, detector response,
limited pinhole diameter, sensitivity) into ray-driven
reconstruction.9–11
Table 1 gives an overview of the current status of
absolute quantification in preclinical SPECT. Seven recent
articles compared ground-truth measurements to micro-
SPECT results.4,12–17 Wu and colleagues achieved a
quantification error of 2 to 4.8% for 99mTc and 3.7 to
9% for 111In using system matrix measurements in their
reconstruction.12,14 With direct modeling, an error less
than 10% was calculated regardless of the radioisotope
used.13,15–17 Lee and Chen studied the errors obtained
from a parallel-hole setup and achieved low errors for
99mTc (, 2%).13 However, filtered back projection was
used to reconstruct their emission data.
Only three studies compared in vivo to ex vivo
data.4,15,16 Unfortunately, the data reported in those
publications lack some aspects. In Vanhove and colleagues,
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a clinical dual-head system was used, retrofitted with a
pinhole collimator.16 Direct modeling of attenuation and
scatter reduced the quantitative error to 27.9 6 10.4%.
No PVE correction was applied, and no data are available
for other isotopes. In Cheng and colleagues, the iterative
reconstruction method was stopped well before conver-
gence at only 24 maximum likelihood expectation
maximization (MLEM) iterations, and no results were
shown for 99mTc.4 Lastly, Finucane and colleagues used
uncorrected reconstructions.15
The aim of this work was to demonstrate the feasibility
of in vivo absolute quantitative microSPECT using direct
model–based corrections for 99mTc and 111In, alleviating
the need to measure the system matrix for each isotope.
Both isotopes encompass a range of photopeaks that serve
as a good testing ground. The errors from a standard
commercially available SPECT/computed tomography
(CT) system with a multipinhole collimator are reported.
All calibration and reconstruction implementations were
not provided by the system vendor but were implemented
by us.
For the in vivo study, we focused on these two
tracers: 99mTc-dimercaptosuccinic acid ([99mTc]DMSA)
and [111In]octreotide. [99mTc]DMSA is used to assess renal
function18,19 and, preclinically, is mostly used as an
indicator of tubular functioning after 90Y therapy.20 A
system resolution better than 1 mm is needed to delineate
the functional renal cortex in mice,21 necessitating PVE
correction and CT contrast agent to accurately delineate
the kidneys. The second tracer, [111In]octreotide, is a
radioactively labeled octapeptide that pharmacologically
mimics natural somatostatin. It is internalized in neu-
roendocrine tumors expressing somatostatin receptor type
2 (SSTR2) (and, to a lesser extent, SSTR3 and SSTR5).22
Materials and Methods
System
All data were acquired on the trimodal FLEX Triumph-II
system (TriFoil Imaging [formerly Gamma Medica Ideas],
Northridge, CA). Its SPECT subsystem consists of one 80
3 80 pixel cadmium zinc telluride (CZT) detector head,
equipped with a multipinhole collimator. The detector is
5 mm thick, and each pixel has a pitch of 1.6 mm
(2.25 mm2 active area). A five-pinhole collimator with
Table 1. Review of Recent Preclinical Quantification Errors Reported in the Literature
Isotope System Type of Study Error (%) Reference
Phantom experiments
99mTc X-SPECT (parallel hole) Rat-sized uniform phantom 6 1.9 13
99mTc X-SPECT (parallel hole) 4-quarter phantom 2.2–3.4 13
99mTc X-SPECT (parallel hole) Concentric phantom 6 2.0, 6 35.0 13
99mTc U-SPECT-II* Homogeneous phantom 21.7 12
99mTc U-SPECT-II Homogeneous phantom 4.8 14
99mTc U-SPECT-II Point sources in ex vivo rat 26.2 to 4.8 12
99mTc U-SPECT-II Point sources in ex vivo rat 2.0 14
99mTc NanoSPECT/CT{ 3-vial phantom , 10 15
99mTc Dual-head clinical camera, single pinhole 9-vial phantom 25.1 to 1.2 16
99mTc Dual-head clinical camera, multipinhole 9-vial phantom 20.3 to 4.1 16
111In U-SPECT-II Homogeneous NEMA 9.1 14
111In U-SPECT-II Point sources in ex vivo rat 3.7 14
111In NanoSPECT/CT 3-vial phantom 8–11 15
111In NanoSPECT/CT Corning tubes with 2 inserts 6 5 4
125I U-SPECT-II Homogeneous NEMA 24.0 14
125I U-SPECT-II Point sources in ex vivo rat 2.1 14
201Tl U-SPECT-II Homogeneous NEMA 7.3 14
201Tl U-SPECT-II Point sources in ex vivo rat 3.3 14
In vivo experiments
99mTc Dual-head clinical camera, multipinhole In vivo mouse liver 29.5 to 27.9 16
111In NanoSPECT/CT In vivo rat kidney and liver 29 and 9 4
CT 5 computed tomography; NEMA 5 National Electrical Manufacturers Association; SPECT 5 single-photon emission computed tomography.
*MiLabs, Utrecht, The Netherlands.
{Bioscan, Inc., Washington, DC.
2 Vandeghinste et al
1.0 mm diameters was fitted 75 mm from the detector and
positioned 55 mm from the axis of rotation, leading to an
FOV of 68 mm per pinhole. Figure 1A depicts the amount
of pinhole multiplexing.
Because only one camera head is installed in our system
instead of the possible four cameras, we doubled the
acquisition time per view and doubled the injected dose.
These two countermeasures led to a fourfold increase in
collected data, as if the system had four heads. This resulted
in a SPECT acquisition protocol using 64 views over a 360u
total rotational angle, with an exposure of 2 minutes per
projection view. All data were acquired in one bed position.
System Calibrations
List-mode output was acquired to obtain finer control
over the conversions to sinograms. This allowed us to use
our own developed software, without having to use the
software included with the commercial system. The list-
mode output was converted into a sinogram by counting
the detected events per pixel. Each detected event was
decay corrected to the start of the SPECT acquisition. The
channel number was converted to photon energy by
applying a quadratic calibration equation. The equation
coefficients were determined by least squares fitting
channel numbers to the known photopeak energies of
the radioisotopes 99mTc and 111In (including the 23 keV
x-ray peak). The data were acquired from low-count point
sources placed 1 m away from the uncollimated detector.
This resulted in the following per pixel equation:
E~1:4858E-5 V2z0:0719 Vz9:3624,
with V as the detected channel number and E as the
calibrated energy value (keV). There is a clear nonlinear
gain on the channel number, together with a baseline offset
for the number of dark counts. The nonlinear gain is a
compensation for the quadratic increase in electron cloud
diameter at increasing photon energies.23 Larger electron
clouds lead to more charge sharing, which decreases the
collected charge per pixel and thus the recorded energy.
The resulting measured spectra are plotted in Figure 1B. The
energy resolution was measured by fitting a gaussian
function to the photopeaks acquired from the point source.
In the case of the 171 keV peak from 111In, the downscatter
from the 245 keV peak was subtracted from the spectrum
first. The downscatter was estimated by the average number
of photons between 187 and 215 keV. The resulting energy
resolution was 5.3% for 140.5 keV (99mTc), 4.8% for 171.3 keV,
and 3.3% for 245.4 keV (111In).
The SPECT system geometry was further charac-
terized by a multipinhole calibration method using three
point-sources.24,25
SPECT Reconstruction Including Corrections
Iterative Reconstruction Algorithm
As a starting point, all data were first reconstructed using
the vendor-provided SPECT reconstruction software. This
software is based on an ordered subset expectation
maximization (OSEM) implementation. The data are
precorrected for radioactive decay. The photopeak window
width was always set to 10% of the photopeak energy. The
OSEM reconstruction algorithm was used and was set to
10 iterations and 8 subsets, with a voxel size of 0.5 mm.
Next, the one-step-late ordered subset expectation
maximization (OSL-OSEM) algorithm26 was implemented
in CUDA. A seven-ray pinhole diameter subsampling
scheme was used to provide resolution recovery.10,17 To
Figure 1. A, Overlap of individual
pinhole projections, annotated with
the number of overlapping pinholes in
each region. B, Measured spectra of
99mTc and 111In.
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reduce the resulting Gibbs artifacts and smooth the
images, an edge-preserving smoothing term was also
incorporated, based on a bayesian rule penalty term.26,27
The image denoising was weighted depending on each
voxel belonging to significant edges or not,27 such that
volumes were not smoothed across anatomic boundaries.
The edge map of the CT image was therefore first
thresholded,28 after which the neighboring voxels of edges
were searched for.27 Those neighbors form the areas
wherein spillover may occur with conventional smoothing.
This previous information was used in a one-step-late
scheme to allow quadratic smoothing in edge-less areas,
whereas the spillover areas were left unsmoothed.27 We
empirically set the regularization factor, which determines
the magnitude of smoothing applied. All reconstructions
ran for 50 iterations with 8 subsets29 per iteration,
reconstructing 1203 0.5 mm 3 0.5 mm 3 0.5 mm voxels.
Scatter Correction
Scatter was measured during list-mode conversion, using
the dual-energy window (DEW)30 and the five-energy
window (FEW) method31 for 99mTc and 111In, respectively.
The photopeak and scatter windows were empirically
selected based on the calibrated spectra (Figure 1B), taking
into account the asymmetrical peak. Table 2 shows the
different energy windows used for each radioisotope.
Photon scatter was corrected by adding the measured
scatter to the forward-projected estimate inside the
reconstruction algorithm. In scatter correction, usually
a Butterworth filter is applied to smooth the scatter
fraction32 to approximate the low-frequency nature of the
scatter fraction. For the system under study here, we
reduced the noise with a median filter (two-pixel radius)
instead of the Butterworth filter.16 This filter is edge
preserving and will not move data across pinhole
boundaries in multiplexing systems.
Sensitivity Correction
Each three-dimensional sample measured in the projectors
is corrected for a distance- and angle-dependent factor,
taking an enlarged pinhole diameter into account due to
photon penetration.10,33 Detector sensitivity is implement-
ed by attenuating the incoming ray with a factor
dependent on the incidence angle and the attenuation of
CZT for the isotope used.
Attenuation Correction
Attenuation was corrected for by using data acquired with
the CT subsystem of the FLEX Triumph-II, mounted in
the same gantry as the SPECT subsystem. This provides
optimal hardware-based coregistration. All CT images
were acquired on a 2,368 3 2,240 pixel detector (pitch
50 mm) using 512 views. A peak voltage of 75 kVp,
exposure time of 345 ms, and tube current of 510 mA were
chosen, with magnification 32, leading to a FOV of 59.2 3
56 mm. The total acquisition time was 13 minutes. All CT
data were reconstructed using the maximum likelihood for
transmission tomography (MLTR)34 algorithm to a voxel
matrix with isotropic voxel pitch of 100 mm, leading to an
image with 592 3 592 3 560 voxels. The implementation
uses the same ray-driven core as the SPECT reconstruction.
The reconstructed images were bilinearly scaled35 into
attenuation values without coherent scattering as scatter
correction was added separately. This high-resolution
attenuation map was used directly in the forward projector.
Quantitative Calibration
One last calibration is needed to relate the reconstructed
count density to the radioactivity concentration (MBq/mL).
A small amount of known activity was scanned with the
same protocol used during the other scans in this study. For
99mTc, a point source of 10.61 MBq was used. The activity of
the 111In point source was equal to 4.31 MBq. The scaling
factor was calculated by dividing the known activity of the
calibration vial by the total number of reconstructed counts
times the volume per voxel.16 By multiplying a recon-
structed image with such a scaling factor, an image with unit
MBq/mL per voxel is obtained. The calibration vial was
reconstructed without corrections as attenuation and scatter
are assumed to be negligible due to the small volume size of
a point source. For radioisotopes that emit photons in
multiple photopeaks (eg, 111In), each photopeak was first
Table 2. Specific Technique and Scatter Windows Used for 99mTc and 111In
Photopeak Window(s) (keV) Scatter Window(s) (keV) Technique
99mTc 128–150 126–129 DEW27
111In 164–182; 238–256 160–168; 180–200; 236–239 FEW28
DEW 5 dual-energy window; FEW 5 five-energy window.
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reconstructed separately with all possible correction factors
enabled. After summing the final reconstructed images into
a single image, it was multiplied by the scaling factor
determined from the summed reconstructions of the
calibration vial. As the scaling factor was determined from
the total number of reconstructed counts, the isotope
branching fraction is implicitly accounted for.
Phantom Experiments
The phantom design for the validation study is based on the
image quality phantom described in the National Electrical
Manufacturers Association (NEMA) NU 4-2008 specifica-
tions.36 The phantom dimensions are illustrated in Figure 2.
Two experiments were conducted to evaluate the quantitative
accuracy for the two isotopes. The largest compartment
was filled with a 1:1 ratio activity and the two smaller
compartments with an 8:1 and 2:1 ratio. To allow delineation
of all three compartments on the CT images, 0.375 mL
iodine-based contrast agent (Visipaque 320 mg I/mL, GE
Healthcare, Little Chalfont, Buckinghamshire, UK) was
added to the 8:1 compartment, the 2:1 compartment received
0.750 ml contrast agent, and no contrast was added to the
background compartment. Therefore, the radioisotope was
first diluted with distilled water in a separate vial while
weighing to obtain the correct concentrations. After measur-
ing the concentration in the vial with the gamma counter,
iodine contrast was added to this vial by pipetting the correct
volume. If done beforehand, the iodine would attenuate the
ground-truth gamma-counter measurements. Part of the
contained volume was then used to fill the corresponding
phantom compartment. The final activity concentrations can
be found in Table 3. The technical specifications of the three
compartments were used to select volumes of interest (VOI).
These VOI were shortened axially to exclude air bubbles. This
resulted in two cylindrical volumes of diameter 8 mm and
height 5 mm for the 8:1 and 2:1 compartments and one
cylindrical volume of diameter 30 mm and height 10 mm for
the 1:1 compartment. The quantitative analysis consisted of
measuring the mean activity in each compartment and
comparing this to the known value.
In Vivo Small-Animal Imaging
Two in vivo studies were used to determine the absolute
quantification error in realistic preclinical experiments.
The Ghent University ethical committee approved all
animal experiments (ECD 12/53).
[99mTc]DMSA
BALB/c mice were selected with weight 26 6 1 g and age
11 6 1 wk (n 5 6). Anesthesia was induced using 4%
isoflurane; for maintenance of the anesthesia, the con-
centration was set at 1.7%. All mice were injected in
the lateral tail vein with 78 6 3 MBq [99mTc]DMSA
(TechneScan DMSA, Mallinckrodt Medical BV, Petten,
The Netherlands). We aimed for a synchronous start of
the SPECT scan 4.5 hours postinjection to maximize the
uptake of the DMSA in the kidneys.21 To visualize the
kidneys on the CT images, 1 hour before the SPECT scan,
an iodine-based contrast agent (Visicover ExiTron V,
Miltenyi Biotec, Bergisch-Gladbach, Germany) was injected
into the lateral tail vein (4 mL/g). A pilot test had shown that
such a protocol results in a maximal contrast increase in the
kidneys between 30 and 60 minutes postinjection. Therefore,
the microCT scan was started 30 minutes after administering
the contrast agent. The 128-minute SPECT acquisition was
started after the microCT scan was finished. Immediately
following the SPECT scan, the animals were euthanized by
cervical dislocation and a blood sample was taken by cardiac
puncture. Both kidneys were dissected, rinsed with physio-
logic saline, dried, and weighed. Kidney weight was
converted into volume by assuming a 1.05 g/mL density.37
All samples were measured in a NaI(Tl) well-type gamma
counter, calibrated with activity measured in the same dose
30
33.3
33.5
8
15
15
Figure 2. Technical specifications (units mm) for the SPECT
quantification phantom. The dashed line is the location of the other
cross-section view.
Table 3. Dose Calibrator–Measured Activity Concentrations in
the NEMA Phantom
Isotope 1:1 (MBq/mL) 2:1 (MBq/mL) 8:1 (MBq/mL)
99mTc 2.84 6.03 21.05
111In 2.95 4.51 18.38
NEMA 5 National Electrical Manufacturers Association.
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calibrator as used for the in vivo experiment. The kidney
VOI were determined by thresholding the kidneys on the
reconstructed CT images. The total activity and volume
inside the VOI were recorded. The reported activity then
equals the VOI activity subtracted by the blood activity
concentration times the vascular volume fraction (VVF) in a
kidney at 0.27 mL/g kidney weight.38 The kidney weight was
determined from the same VOI volume.
[111In]Octreotide
A human non–small cell lung carcinoma (NCI-H727) was
chosen as a neuroendocrine tumor model. CD-1 nude
mice (n 5 10) (Charles River, France) were injected
subcutaneously with 5 3 106 cells in the right hind leg. The
animals without a palpable tumor were euthanized 3 weeks
after inoculation. All remaining mice (n 5 6, age 13 6
1 wk, weight 27 6 2 g) were anesthetized and then injected
with 31 6 1 MBq [111In]octreotide (Octreoscan, Covidien
Belgium, Mechelen, Belgium) via the lateral tail vein. The
microCT scan was started 23 hours postinjection, after
which the 128-minute microSPECT scan was started.39
Immediately following the SPECT scan, the animals were
euthanized by cervical dislocation, and a blood sample was
taken by cardiac puncture. The tumor was excised from
the thigh and rinsed in physiologic saline, dried, and
weighed. Tumor weight was converted into volume
assuming a 1 g/mL density.40 All samples were measured
in a calibrated NaI(Tl) well-type gamma counter.
The CT image was used to delineate the boundaries of
each tumor. The total activity and volume inside the VOI
were measured. Because VVF is unknown for these
tumors, we assumed a value of 5% mL/g tumor tissue.41
The reported activity then equals the reconstructed activity
concentration subtracted by the blood activity multiplied
by the VVF.
Data Analysis
All data were analyzed by comparing fully corrected data
to the vendor’s software and to our uncorrected data.
Uncorrected data refers to data corrected only for decay,
geometric sensitivity, and quantitative calibration. The
corrected data are always corrected for decay, geometric
sensitivity, resolution recovery, edge-preserving smooth-
ing, quantitative calibration, and the VVF, with additional
attenuation correction and/or scatter correction. All VOI
were analyzed using the open-source AMIDE software
package (version 1.0.4).42 Quantification errors were
calculated per VOI and then averaged. The paired t-test
was used to quantify significant differences between the
quantification from reconstructed data and the known
ground-truth values. Furthermore, a Bland-Altman analy-
sis was conducted to further evaluate the agreement
between reconstructed values and ground-truth values.
Results
Phantom Measurements
Figure 3 shows a transaxial and a coronal slice through the
reconstructed SPECT image obtained after applying all
corrections for both isotopes. Figure 4 correlates the
activity concentrations measured on the reconstructed
images to the activity concentrations measured in the dose
calibrator. The uncorrected data and the fully corrected
data were fit with a dashed line and a full trend line,
respectively.
As can be seen from Figure 4, attenuation correction has
the biggest influence on the quantitative accuracy. When all
corrections were applied, except for scatter correction, the
errors decreased on average from 2.78 6 2.62 MBq/mL to
0.30 6 0.25 MBq/mL for 99mTc, from 1.91 6 1.23 MBq/mL
to 20.80 6 1.66 MBq/mL for the low-energy peak of 111In,
and from 1.48 6 1.58 MBq/mL to 20.53 6 0.58 MBq/mL
for the high-energy peak of 111In. Combining both peaks
leads to a decrease from 1.77 6 1.34 MBq/mL to 20.72 6
1.30 MBq/mL for 111In, a small overcorrection. When all
corrections are applied, including scatter correction, the
quantification errors decrease from 2.78 6 2.62 MBq/mL to
0.88 6 0.85 MBq/mL for 99mTc, from 1.91 6 1.23 MBq/mL
to 20.02 6 1.04 MBq/mL for the low-energy peak of 111In,
A
transversal coronal
B
coronaltransversal
0 MBq/ml
2 MBq/ml
0 MBq/ml
15 MBq/ml
Figure 3. Reconstructed images of
the NEMA phantom for (A) 99mTc
and (B) 111In. The volumes of interest
used in the evaluation are depicted in
white.
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and from 1.48 6 1.58 MBq/mL to 0.08 6 0.51 MBq/mL
for the high-energy peak of 111In. Combining both peaks
decreases the error from 1.77 6 1.34 MBq/mL to 0.01 6
0.79 MBq/mL. Although these errors are low on average, a
one-sample t-test of each value to the known reference
value shows that each value is significantly different (p ,
.01) from the reference data, even after applying all
corrections. The quantification errors for the separate
vials are included in the summarized results in Table 4.
Generally, a small undercorrection is found for 99mTc,
whereas the data for 111In show a small overcorrection.
For 111In, the largest error can always be found in the 1:1
background vial.
Two-sample t-tests for the three different 111In data
sets (low, high, and combined photopeaks) show a
significant difference for the three pairs for the 1:1
background vial, a significant difference between low and
high for the 2:1 vial, and a significant difference for the
8:1 vial between low and high and between combined and
low. The other combinations show no significant error
difference.
In Vivo Small-Animal Imaging
Figure 5 shows example reconstructions of the recon-
structed in vivo data. Because of the difference in injected
dose and tracer specificity, the background activity is much
more of a confounding factor for [111In]octreotide (see
Figure 5B) than for [99mTc]DMSA (see Figure 5A). Table 5
shows average absolute errors and average relative errors
for both studies. For [111In]octreotide, the separate
quantification of each photopeak (low 5 171 keV, high
5 245 keV) is also included. Only 10 data points were
available for [99mTc]DMSA (instead of 12 kidneys
harvested from 6 mice) as one acquisition failed due to
the animal waking up during the SPECT scan.
The average activity reduction due to the VVF is 0.068 6
0.026 MBq for the [99mTc]DMSA kidneys and 0.004 6 0.003
MBq for the [111In]octreotide tumors. A paired t-test indicated
that there was no significant difference between the reference
data and the fully corrected data whether the VVF was used or
not. However, applying the VVF significantly (p , .01)
decreased the quantification error for [99mTc]DMSA from
0.038 6 0.198 MBq/mL to 20.030 6 0.201 MBq/mL. For
Figure 4. Correlation between the reconstructed and the ground-truth values for 99mTc (top left) and 111In (top right) with both peaks combined.
The 171 keV and 245 keV peaks of 111In are separated in the bottom row.
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[111In]octreotide, a significant (p , .05) increase of 0.008 6
0.040 MBq/mL to 0.012 6 0.038 MBq/mL was found.
Figure 6 correlates the measured activity concentration
to the reference ex vivo activity concentration. For
[99mTc]DMSA, there is a significant difference (paired t-test,
p, .01) comparing the uncorrected data to the reference data,
whereas the difference between fully corrected data and the
same reference data is not significant (p 5 .64). Also for
[111In]octreotide, a paired t-test on the summed two-peak
reconstruction shows a significant difference (p, .05) between
the uncorrected and reference data, whereas no significant
difference (p5 .113) remained when comparing the corrected
and the reference data. The goodness of fit improves when all
corrections are applied but is worse for 111In (R2 5 .778 and
.823) than for 99mTc data (R2 5 .991 and .995).
A Bland-Altman analysis is presented in Figure 7. A
one-sample t-test to zero mean difference indicates a
significant absolute systematic error for the difference
between the uncorrected data and the reference data, for
both isotopes (99mTc: p , .01; 111In: p , .05). This
systematic error is relatively lower for 99mTc than for 111In.
These results indicate a greater agreement between the
reference and the corrected data than between the
reference and the uncorrected data.
Discussion
Our study shows that a quantification error of less than 5% is
achievable with 99mTc and 111In. This was accomplished with
model-based iterative SPECT reconstruction on a standard,
commercially available multipinhole microSPECT scanner.
All data were reconstructed using direct physical modeling
instead of system matrix measurements.
Our phantom results indicate that a decrease in
quantification error is primarily influenced by attenuation
correction. The influence of scatter correction is much
smaller. This is partially caused by the CZT detector, which
leads to a tail of low-energy events.43 Thus, few scattered
photons will be included in the photopeak window, at the
expense of a lower amount of primary photons, increasing
the statistical noise. This agrees with the findings of Chen
and colleagues, who concluded that narrowing the energy
windows is an effective way to correct for scatter in 99mTc
and 111In studies, provided that sufficient energy resolution
is available.44 It should be stressed that scatter correction
will increase in importance when other detectors are used
(ie, with lower energy resolution) but will remain less
important than attenuation correction in small-animal
SPECT.6 This is also in agreement with the findings of Lee
and Chen, who determined that attenuation is the prime
factor to consider for this CZT-based system.13
Although the presented results are promising for
routine use of absolute quantification in in vivo SPECT
imaging, some issues were noticed during the experimental
work. First, the importance of blood volume correction is
not as clear as reported in Cheng and colleagues.4 Applying
blood volume correction significantly changes the absolute
Table 4. Quantitative Errors Obtained from the NEMA Phantom with the Vendor-Provided Software and with Our Own Software, before
and after All Corrections Were Applied
1:1 2:1 8:1
MBq/mL % MBq/mL % MBq/mL %
99mTc
Vendor 0.41 6 0.70 14 6 25 1.81 6 1.29 30 6 21 6.06 6 3.53 29 6 17
Uncorrected 0.71 6 0.53 25 6 19 1.90 6 1.05 32 6 17 5.73 6 3.67 27 6 17
Corrected 0.15 6 0.66 5 6 23 0.68 6 1.29 11 6 21 1.81 6 4.36 9 6 21
111In
Vendor 1.16 6 0.43 39 6 15 0.70 6 0.75 16 6 17 3.52 6 2.11 19 6 11
Uncorrected 1.24 6 0.37 42 6 12 0.77 6 0.49 17 6 11 3.29 6 1.64 18 6 9
Corrected 0.92 6 0.33 31 6 11 20.47 6 0.67 210 6 15 20.42 6 1.94 22 6 11
111In—low
Uncorrected 1.47 6 0.32 50 6 11 0.95 6 0.47 21 6 10 3.30 6 1.64 18 6 9
Corrected 1.16 6 0.39 39 6 13 20.46 6 0.76 210 6 17 20.83 6 2.03 25 6 11
111In—high
Uncorrected 0.76 6 0.31 26 6 11 0.38 6 0.50 8 6 11 3.28 6 1.79 18 6 10
Corrected 0.39 6 0.44 13 6 15 20.51 6 0.68 211 6 15 0.36 6 1.90 2 6 10
NEMA 5 National Electrical Manufacturers Association.
Positive errors are undercorrections; negative errors are overcorrections.
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0 MBq/ml
20 MBq/ml
0.5 MBq/ml
0 MBq/ml
A
B
Figure 5. Reconstructed (A) [99mTc]
DMSA data and (B) [111In]octreotide
data. The tumor volume of interest is
shown in yellow for data set B.
Table 5. Summary of Quantitative Errors Obtained from In Vivo Studies with the Vendor-Provided Software, with Our Own Software
before Corrections, and after Applying All Corrections ([99mTc]DMSA: n 5 10; [111In]Octreotide: n 5 6)
Reference Vendor Error Uncorrected Error Corrected Error
Tracer MBq/mL MBq/mL % MBq/mL % MBq/mL %
[99mTc]DMSA 8.42 6 2.77 1.12 6 0.37 13.6 6 3.1 1.31 6 0.33 16.2 6 2.8 20.03 6 0.20 20.3 6 2.1
[111In]octreotide 0.35 6 0.09 0.09 6 0.13 22.4 6 29.0 0.06 6 0.01 16.7 6 10.1 0.01 6 0.04 2.2 6 10.6
[111In]octreotide—low — — 0.08 6 0.05 22.7 6 11.4 0.03 6 0.05 8.1 6 11.8
[111In]octreotide—high — — 20.01 0.02 23.8 6 8.6 20.06 6 0.01 218.8 6 8.5
DMSA 5 dimercaptosuccinic acid.
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quantification values. For [99mTc]DMSA, this leads to a
lower quantification error, whereas for [111In]octreotide,
the quantification error increases. This could be due to a
misestimated blood volume for the H727 tumors.
Although we measured the blood activity concentration
by a heart puncture, a gamma-counting blood sampler can
also be used. This was unavailable to us at the time. Few
data of the VVF of different tissues are available, which
makes this correction difficult in practice. One possible
solution would be to directly measure the VVF using in
vivo magnetic resonance imaging (MRI),41,45 which would
also account for intraspecies differences.
An important limitation of the DMSA study is the
delineation of the renal cortex. The complete kidney was
Figure 6. Quantification error for the [99mTc]DMSA (left) and [111In]octreotide (right) studies. The diagonal is the ground truth.
+1.96 SD
-1.96 SD
Mean
-0.66
-1.31
-1.96
+1.96 SD
-1.96 SD
Mean0.42
0.03
-0.36
+1.96 SD
-1.96 SD
+1.96 SD
-1.96 SD
Mean
Mean
0.02
-0.06
-0.15
-0.09
-0.01
0.06
A
B
Figure 7. Bland-Altman plots for (A) [99mTc]DMSA and (B) [111In]octreotide, comparing reference activity concentration and uncorrected
reconstructed data (left) and reference activity concentration and corrected reconstructed data (right).
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delineated and compared to the dissected complete kidney,
instead of quantifying only the renal cortex. This was done
because the renal cortex is still difficult to delineate on
contrast-enhanced CT and because the cortex is also
difficult to separate from the medulla during dissection.
However, edge-preserving smoothing is still necessary to
limit the overspill of activity in nonrenal tissue.
A second issue is the low system sensitivity in pinhole
SPECT, which is combined with low biologic uptake in
typical preclinical studies. The H727 cell line showed an
uptake of only 1.4 6 0.5% ID/g from [111In]octreotide,
resulting in an activity of 151 6 40 kBq per tumor during the
SPECT acquisition. The results obtained show that in vivo
quantification is still possible at such a low activity, which is
more than an order of magnitude lower than the activity
reported by Finucane and colleagues,15 when normalized to
the low sensitivity of our system.46 Unfortunately, increasing
the activity will not be possible for all tracers due to specific
tracer kinetics (eg, irreversible binding).
Some system design ideas allow for pinhole systems with
increased sensitivity. One is the multiplexing of pinholes, as
is already used in the X-SPECT system. Several research
groups have shown that multiplexing leads to image
artifacts such as image nonuniformities and ghost activity
due to the ambiguity of the projected data in overlapping
regions.47–51 A uniform phantom scanned with the X-
SPECT system has already been shown to exhibit some
nonuniformities (see Figure 8 in Deleye and colleagues46)
when a multipinhole collimator is used. However, the extent
of multiplexing artifacts is dependent on the activity
distribution and the geometric system design.47 A similar
nonuniformity was noticed in the uniform part of the
phantom study (see Figure 3). This may influence the
quantification error when only a small VOI is analyzed.
Conclusion
We have shown that absolute in vivo quantification is
possible in microSPECT using direct modeling in iterative
reconstruction, without the need for explicit measurements
of the system matrix. An absolute in vivo quantification
error smaller than 5% was achieved for two typical isotopes.
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